General Growth Properties Files Plan of Reorganization and Disclosure Statement

Plan Allows Company to Emerge from Chapter 11 with Strong Financial Foundation
and Clear Growth Strategy

GGP Targeting Emergence from Chapter 11 in October 2010
CHICAGO–(Business Wire)–
General Growth Properties, Inc. (NYSE: GGP) today announced it has filed its
proposed Plan of Reorganization (the “Plan”) and Disclosure Statement with the
United States Bankruptcy Court for the Southern District of New York. Under the
terms detailed in the filing, GGP anticipates it will emerge from Chapter 11
protection in October 2010.

GGP expects to emerge from its financial restructuring with a significantly
improved balance sheet and substantially less debt, providing it with a strong
financial foundation to execute on its growth strategy going forward. Since
December 2009, GGP has successfully and consensually restructured approximately
$15 billion in project-level debt. Under the Plan, GGP will satisfy its debt and
other claims in full, provide a substantial recovery for shareholders and
implement a recapitalization with $7.0 billion to $8.5 billion of new capital.
At emergence, GGP will split itself into two separate publicly traded companies
(“New GGP” and “Spinco”), and current shareholders will receive common stock in
both companies.

“The filing of our Plan of Reorganization and Disclosure Statement is an
important milestone in our restructuring process,” said Adam Metz, chief
executive officer of GGP. “We are extremely pleased with our success in the
restructuring to date, and we look forward to continuing to work productively
with all of our stakeholders to finish building the strong capital structure
that will sustain GGP in the future. We appreciate the support of our employees,
customers, suppliers, lenders and partners throughout this process, which has
been instrumental in our ability to reach this important milestone.”

Mr. Metz continued, “With our restructured balance sheet and clear strategic
focus, GGP will emerge from Chapter 11 well-positioned to build on our
leadership position in the industry. The New GGP will remain the second-largest
shopping mall owner and operator in the country, with more than 180 properties
in 43 states, and will focus on largely stable, income-producing shopping malls
and other real estate assets. Our management team is committed to creating
compelling experiences for shoppers and strong partnerships with tenants, which
we expect in turn to drive long-term value for our shareholders. At the same
time, Spinco will hold a diversified portfolio of properties with little debt
and with near-, medium- and long-term development opportunities, including GGP`s
master planned communities segment and a series of mixed-use and mall
development projects in premier locations. Spinco will be run by its own
separate Board and management team equally committed to its long-term success. I
am confident that both companies will be extremely well positioned to succeed.”

The Plan is based on investment agreements with affiliates of Brookfield Asset
Management, Fairholme Capital Management and Pershing Square Capital Management,
which have committed to provide $8.55 billion in capital as follows:

* $6.3 billion of new equity capital at $10.00 per share of New GGP.
* $250 million backstop equity commitment for a rights offering by Spinco at
$5.00 per share.
* $1.5 billion backstop debt commitment for a New GGP credit facility by
Brookfield, Pershing Square and Fairholme.
* $500 million backstop equity commitment by Brookfield and Pershing Square for
a rights offering by New GGP at $10.00 per share.

In addition, GGP has executed an agreement with the Teacher Retirement System of
Texas (TRS), a public pension plan, for an investment of $500 million in shares
of New GGP common stock at $10.25 per share.

These investment agreements also provide GGP with significant flexibility to
optimize its emergence capital structure. Key features of these agreements
provide GGP the option to replace a portion or all of the capital being provided
by Fairholme, Pershing Square and TRS with the proceeds of equity issuances at
more advantageous pricing. To determine whether it can utilize these options,
GGP intends to access the public capital markets. As a result, GGP intends to
file a registration statement on Form S-11 with the Securities and Exchange
Commission to raise equity capital prior to or shortly after emergence from
Chapter 11.

The Bankruptcy Court has set the hearing to consider approval of the Disclosure
Statement for August 19, 2010, at 10:00 am EDT. Following Bankruptcy Court
approval of the Disclosure Statement and related voting solicitation procedures,
GGP will solicit acceptances of the Plan and seek its confirmation by the
Bankruptcy Court.

A PowerPoint presentation summarizing GGP`s reorganization process and its
proposed new capital structure is available at

http://www.ggp.com/content/Docs/reorganization072010.pdf.

UBS Investment Bank and Miller Buckfire & Co. LLC are serving as financial
advisors to General Growth Properties, and Weil, Gotshal & Manges LLP and
Kirkland & Ellis LLP are acting as legal counsel to the Company.

ABOUT GGP

GGP currently has ownership interest in, or management responsibility for, over
200 regional shopping malls in 43 states, as well as ownership in planned
community developments and commercial office buildings. The Company`s portfolio
totals approximately 200 million square feet of retail space and includes over
24,000 retail stores nationwide. The Company`s common stock is traded on the New
York Stock Exchange under the symbol GGP.

NOTE

With respect to GGP`s efforts to raise equity capital to replace some or all of
the Pershing Square, Fairholme and Texas Teachers commitments, as noted, the
Company intends to file a registration statement relating to these securities
with the Securities and Exchange Commission. The securities may not be sold nor
may offers to buy be accepted prior to the time the registration statement
becomes effective. This press release does not constitute an offer to sell these
securities.

FORWARD LOOKING STATEMENTS

This press release contains forward-looking statements. Actual results may
differ materially from the results suggested by these forward-looking
statements, for a number of reasons, including, but not limited to, our ability
to successfully complete our plan of reorganization and emerge from bankruptcy,
our ability to refinance, extend, restructure or repay our near and intermediate
term debt, our substantial level of indebtedness, our ability to raise capital
through equity issuances, asset sales or the incurrence of new debt, retail and
credit market conditions, impairments, our liquidity demands and retail and
economic conditions. Readers are referred to the documents filed by General
Growth Properties, Inc. with the Securities and Exchange Commission, which
further identify the important risk factors which could cause actual results to
differ materially from the forward-looking statements in this release. The
Company disclaims any obligation to update any forward-looking statements.

General Growth Properties, Inc.
David Keating, Vice President of Corporate Communications
(312) 960-6325
david.keating@ggp.com

Copyright Business Wire 2010

Sallerson-Troob Deploys New Orc Software Trading Functionality for Volatility Trading

STOCKHOLM & CHICAGO–(Business Wire)–
Orc Software (SSE:ORC), the leading global provider of technology for advanced
trading and connectivity solutions, announces that Chicago-based trading firm
Sallerson-Troob LLC “Sallerson-Troob” has deployed Orc Trading as a volatility
trading solution for the firm. The order was booked in Q1 2010, and the contract
is based on Orc`s licensing subscription model.

Sallerson-Troob is taking advantage of new functionality from Orc Software that
allows traders to quickly fit volatility curves during the trading day. Managing
volatility during the trading day can be time consuming and difficult. Orc
Trading now allows users to access the full richness of Orc`s volatility
management capabilities to automatically fit volatility curves for multiple
instruments with a single click, letting the trader focus on identifying trading
opportunities and reducing the time spent on ancillary tasks. This allows
traders to scale their business to more instruments in more markets.

Alan Sartin, Member at Sallerson-Troob, comments, “We used to spend half of our
time working with a trading system and fitting volatilities. With Orc Trading,
we`re now able to do that in one click. Orc Software lets us increase our
trading, find more opportunities, and ultimately make more and better trades.
This functionality, combined with Orc`s excellent support and market reach, will
help us remain competitive in the options market. Sallerson-Troob is actively
seeking new traders and they`ll be able to take advantage of Orc Trading from
day one.”

Akira Yamaguchi, Product Manager at Orc Software, notes, “Our new volatility
curve fitting functionality will help traders, like those at Sallerson-Troob,
maximize opportunities. Being able to manage more options and spot more
opportunities with the trust that your volatilities are good is essential for
today`s options traders. Traders earn their livings capitalizing on
opportunities and refining their market views. A trader`s tools should be an
enabler and not an obstacle.”

“Sallerson-Troob`s deployment of Orc Trading represents our continued growth in
the US,” says Marty Leamy, President Americas, Orc Software. “Proprietary
traders are looking for new tools to gain an edge and Orc is delighted to
provide this functionality to new and existing customers alike.”

Orc Trading is used by leading financial firms worldwide for enhanced, trading
and risk management on electronically traded derivatives. Orc Trading provides
the competitive edge to trade from a single platform, on any listed instrument,
across all asset classes, on 100+ markets. Orc Trading comprises market leading
solutions including among others Orc Trading for Algorithmic Trading, Orc
Trading for Arbitrage, Orc Trading for Market Making, Orc Trading for Risk
Management and Orc Trading for Volatility Trading.

About Orc Software`s revenue model

Standard agreements follow Orc`s licensing subscription model, a flexible
approach designed to streamline the customer on boarding process and provide
ease of access to software updates, together with a mature support framework.
Customers are invoiced quarterly, in advance, and revenue allocated to the
invoicing period.

About Orc Software

Orc Software is the leading global provider of technology and services for
advanced trading in financial instruments. Orc`s competitive edge lies in its
depth of knowledge of the trading world, gained by deploying sophisticated
trading solutions for over 20 years.

Orc Trading and Orc Connect provide the tools for making the best trading and
connectivity decisions with strong analytics, unmatched market access, powerful
derivatives trading support, automated trading strategies and execution, high
performance futures and options trading capabilities, ultra-low latency and risk
management.

Through the acquisition of Neonet, Orc also delivers neutral, high speed
brokerage services to professional market participants, with clients in over 20
countries globally.

With subsidiary CameronTec, Orc is the leading provider of FIX infrastructure
and low latency connectivity.

Orc`s customers include leading banks, trading and market-making firms,
exchanges, brokerage houses, institutional investors and hedge funds.

Orc provides sales and quality support services from its offices across EMEA,
Americas and Asia Pacific.

Orc Software is listed on NASDAQ OMX Stockholm (SSE:ORC).

www.orcsoftware.com

About Sallerson-Troob

Alan Sartin manages traders employing specialized trading strategies within
Sallerson-Troob. His research has led him to choose Orc as his preferred
software partner in the use of all volatility trading.

This information was brought to you by Cision http://www.cisionwire.com

Barry Vasudevan, Marketing Director
Americas, Orc Software
+1 212 351 7624
barry.vasudevan@orcsoftware.com
or
Alan Sartin, Member
Sallerson-Troob
+1 312 362 4080
asartin@stllc.com

Copyright Business Wire 2010

Littelfuse Raises Guidance for Second Quarter

CHICAGO–(Business Wire)–
Littelfuse, Inc. (NASDAQ:LFUS) today announced revised guidance for the second
quarter of 2010 as follows:

* Sales for the second quarter of 2010 are now expected to be in the range of
$155 to $160 million, which represents sequential growth of 7% to 11%. Previous
guidance called for sales in the range of $148 to $153 million.
* Earnings for the second quarter of 2010 are expected to be in the range of
$0.78 to $0.88 per diluted share. Previous guidance called for earnings in the
range of $0.69 to $0.77 per diluted share.

“Electronics demand continues to exceed our forecast in all end markets and all
geographies,” said Gordon Hunter, Chief Executive Officer. “Startco is
performing at the high end of expectations and the electrical fuse business is
steadily improving.”

“Overall, our operations teams have done a very good job ramping up production
to meet increasing customer demand,” said Phil Franklin, Chief Financial
Officer. “Recently, however, we have had a supply interruption at our
semiconductor factory in Taiwan. Equipment failure caused a fire in a limited
area that was quickly brought under control. Production has resumed, but we will
be operating this facility below full capacity for a few months. This is
expected to constrain sales by $2 to $3 million in the third quarter.”

“Orders and backlog remain robust in all geographies, which leads us to believe
we will see typical seasonal strength in the third quarter,” said Hunter. “The
final manufacturing transfers are on track and are expected to deliver
additional savings beginning in the third quarter.”

No conference call will be held in conjunction with this revised guidance.
Littelfuse is scheduled to release financial results for the second quarter on
August 5, 2010.

About Littelfuse

Littelfuse is the worldwide leader in circuit protection, offering the
industry`s broadest and deepest portfolio of circuit protection products and
solutions. Backed by industry-leading technical support, design and
manufacturing expertise Littelfuse products are vital components in virtually
every product that uses electrical energy, including portable and consumer
electronics, automobiles, industrial equipment and telecom/datacom circuits. In
addition to its Chicago, Illinois, world headquarters, Littelfuse has over 20
sales, distribution, manufacturing and engineering facilities in the Americas,
Europe and Asia. Technologies offered by Littelfuse include Fuses; Gas Discharge
Tubes (GDTs); Positive Temperature Coefficient Devices (PTCs); Protection
Relays; PulseGuard ESD Suppressors; SIDACtor Devices; Silicon Protection
Arrays(SPAs); Switching Thyristors; TVS Diodes and Varistors.

For more information, please visit the Littelfuse website at www.littelfuse.com.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of
1995.

The statements in this press release that are not historical facts are intended
to constitute “forward-looking statements” entitled to the safe-harbor
provisions of the PSLRA. These statements may involve risks and uncertainties,
including, but not limited to, risks relating to product demand and market
acceptance, economic conditions, the impact of competitive products and pricing,
product quality problems or product recalls, capacity and supply difficulties or
constraints, coal mining exposures reserves, failure of an indemnification for
environmental liability, exchange rate fluctuations, commodity price
fluctuations, the effect of the company`s accounting policies, labor disputes,
restructuring costs in excess of expectations, pension plan asset returns less
than assumed, integration of acquisitions and other risks which may be detailed
in the company`s Securities and Exchange Commission filings. Should one or more
of these risks or uncertainties materialize or should the underlying assumptions
prove incorrect, actual results and outcomes may differ materially from those
indicated or implied in the forward-looking statements. This report should be
read in conjunction with information provided in the financial statements
appearing in the company`s Annual Report on Form 10-K for the year ended January
2, 2010. For a further discussion of the risk factors of the company, please see
Item 1A. “Risk Factors” to the company`s Annual Report on Form 10-K for the year
ended January 2, 2010.

Littelfuse, Inc.
Philip G. Franklin,
Vice President, Operations Support, CFO (773) 628-0810

Copyright Business Wire 2010

NEC Display Solutions and Technovare Systems Announce New Single Board Computer Options

Four New PC`s Provide Flexibility for Various Digital Signage Applications
Requiring Network Access
CHICAGO–(Business Wire)–
NEC Display Solutions of America, a leading provider of commercial LCD display
and projector solutions, announced today three new single board computer
options, designed to be seamlessly integrated into select NEC large-format
displays, as well as an external PC option. Technovare Systems, Inc., a rising
AV company based in California, has partnered with NEC to design and build the
four new accessories, which are ideal in airports, public information,
healthcare, retail, quick-service restaurants and lobbies.

The new single board computer products can be seen at InfoComm 2010 (NEC Display
Solutions Booth No. N903) on June 9-11, 2010, at the Las Vegas Convention Center
in Las Vegas, Nev.

The NET-SBC-01, NET-SBC-02 and NET-SBC-03 are designed to be seamlessly
integrated into any NEC S Series, P Series or X Series display that contains the
built-in expansion slot. One of the most requested features by customers, the
built-in expansion slot gives users greater flexibility for application types
and offers a clean, professional look to the setup. These components are
frequently added to an existing deployment, making the expansion slot in the
majority of NEC`s large-format displays incredibly valuable.

The modules feature a 1.6GHz Dual Core Atom CPU with Intel Hyper-Threading
technology, 2GB DDR2 and Nvidia 9400 graphic processing unit, which allows for
processing of multiple video formats and the ability to run full high-definition
content at 1080P. These three single board computers provide network access
through the use of existing CAT5 network infrastructures, saving both time and
money. The NET-SBC-01 and -03 models offer Windows XP Pro Embedded operating
system, while the NET-SBC-02 does not have an operating system, providing
flexibility for those end-users who wish to run Linux, Windows Vista or Windows
7. The NET-SBC-02 is ideal in large digital signage deployments, such as
corporate applications where each unit has identical specified requirements, and
end-users can automate the settings on the entire network simultaneously, saving
a large amount of backend time.

“Customers will enjoy the simple upgrade of their current digital signage
systems that comes with the purchase of a single board computer, whether
internal or external,” said Luke Bruschuk, Product Manager for NEC Display
Solutions. “We base our displays on what`s needed in the end-user application
and hope to increase those opportunities by adding these four modules to our
extensive portfolio of accessories.”

The TNETPC-ION is an external PC option designed for those customers who have
the need for more hard drive space (160GB), expanded connectivity (Gigabit
Ethernet, 6 USB 2.0 ports and RS-232) and WIFI. Also operating under Windows XP
Pro Embedded, the TNETPC-ION is fitting for those environments with more robust
needs.

“This venture with NEC Display Solutions has been a wonderful opportunity to
collaborate on a solution truly designed for the end-user`s benefit,” said Barry
Hsieh, Director of International Sales at Technovare Systems, Inc. “The ability
to have network access in a seamless component, enhancing an existing project,
is both cost-effective and hassle-free.”

The NET-SBC-01/02/03 single board computers and the TNETPC-ION external PC will
be available for August shipment at estimated street prices of $899, $749, $899
and $799, respectively, with a 3-year warranty.

About NEC Display Solutions of America, Inc.

Headquartered in Itasca, Ill., NEC Display Solutions of America, Inc., is a
leading designer and provider of innovative desktop LCD monitors, commercial-
and professional-grade large-screen LCD displays, a diverse line of multimedia
and digital cinema projectors, and integrated display solutions. NEC Display
Solutions develops leading-edge visual technology and customer-focused solutions
for a wide variety of markets, including enterprise, healthcare, education and
digital signage. For additional information about NEC Display Solutions of
America monitors, consumers can call (866) NEC-MORE, or visit the website at
www.necdisplay.com. For digital images, please visit

http://www.necdisplay.com/products/digitalmedialibrary/.

About VUKUNET

VUKUNET, powered by NEC Display Solutions of America, is the universal
advertising platform that connects digital out-of-home networks with ad revenue.
VUKUNET is a web-based tool that provides a centralized, automated place for
network owners to connect their screens to advertisers looking to place their
digital ads. Advertisers and ad agencies can use the companion ADVUKU ad-serving
platform to search for the best networks in any location. For additional
information about VUKUNET, visit www.vukunet.com or call 877-805-VUKU. For
VUKUNET logos and digital images, please visit
http://www.vukunet.com/PressResources.aspx. For additional information on
ADVUKU, visit www.advuku.com.

About Technovare Systems, Inc.

Founded in 1996, Technovare has grown to be a leader in networked audio video
systems with applications ranging from digital signage to video on demand.
Equipped with both hardware and software products, Technovare is capable of
providing powerful platforms quickly customizable for a multitude of demanding
applications. For more information please visit http://www.technovare.com.

Philip Anast
Tech Image (for NEC Display Solutions)
(847) 279-0022, x238
philip.anast@techimage.com

Copyright Business Wire 2010

ARIAD Presents Updated Clinical Data on Its Investigational Pan-BCR-ABL Inhibitor, AP24534, in Drug-Resistant Chronic Myeloid Leukemia

~ Additional data on safety and clinical activity against broad spectrumof
BCR-ABL mutations

~ Evidence of major molecular responses and durability of response
CHICAGO–(Business Wire)–
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced updated clinical data
from an ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor,
AP24534, in patients with resistant and refractory chronic myeloid leukemia
(CML). The data confirm strong clinical evidence of hematologic, cytogenetic and
molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor,
in heavily pretreated patients with CML, including those with the T315I mutation
of the target protein, BCR-ABL. The data are being presented this afternoon at
the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
being held in Chicago, IL.

Data on fifty-seven patients in seven dosing cohorts (2, 4, 8, 15, 30, 45 and 60
mg administered orally once daily) are being reported at ASCO. Fifty-three of
the patients have resistant and refractory CML or Philadelphia-chromosome
positive (Ph+) acute lymphoblastic leukemia (ALL). Ninety-four percent of these
53 patients have been treated with, and were resistant to, at least two of the
available first-line and second-line tyrosine kinase inhibitors for CML.
Sixty-six percent of the patients were pretreated with three or more prior
tyrosine kinase inhibitors, including imatinib (Gleevec®), dasatinib (Sprycel®),
and nilotinib (Tasigna®) and investigational agents.

“The updated findings from this study confirm in a larger number of patients,
that AP24534 continues to be well-tolerated and produce beneficial and durable
anti-leukemia activity in patients who have failed prior tyrosine kinase
inhibitor therapy for CML, including patients with the T315I mutation for which
there are no currently available treatments,” stated Moshe Talpaz, M.D.,
Associate Director of Translational Research and Associate Chief of Hematologic
Malignancies, Trotman Professor of Leukemia Research, University of Michigan
Medical Center, and study investigator. “We are highly encouraged by the
documentation of efficacy at the molecular level and the anti-leukemic activity
that looks to be durable. Pending completion of further clinical trials, AP24534
represents a potential significant advance for CML patients who have become
resistant to currently available therapies and who are in great need of new
treatment options.”

Updated results from the open-label, dose-escalating study presented at ASCO
include:

* AP24534 was well tolerated at therapeutic dose levels including the newly
evaluated 45 mg/day dose. This dose cohort was initiated in December 2009. With
the exception of the DLTs of elevated amylase and lipase and grade 2
pancreatitis observed at 60 mg, the safety profile is similar when doses equal
to or greater than 30 mg/day (the dose associated with sustained blood levels
above the target inhibitory concentration) are compared with all doses in the
trial.
* Of the 57 patients treated with AP24534, thirty-seven patients (65 percent)
currently remain on study. At doses equal to or greater than 30 mg/day, 25 of 33
patients (76 percent) continue to be treated with AP24534.
* With this update, molecular responses have begun to emerge. Of 32 resistant
chronic phase CML patients evaluated at least once since baseline, 8 achieved a
major molecular response (MMR), some of them after only 2 months of treatment
with AP24534. Four of these MMRs were seen in patients with the T315I mutation;
4 others were seen in patients with other mutations. These observations are
consistent with the pre-clinical profile of AP24534 as a pan-BCR-ABL inhibitor.
* With longer follow-up now available, responses appear to be durable. Out of 12
major cytogenetic responses (MCyR) in patients with chronic phase CML, 11 remain
on therapy without progression after an average of almost a year on treatment
(327 days). Nine of the 12 patients had cytogenetic response confirmed with at
least a second assessment after three months. Only one patient experienced CML
progression after having achieved a MCyR and this was in a patient enrolled in
the sub-therapeutic 4 mg dose cohort.
* Of 26 chronic phase CML patients evaluable for cytogenetic response across all
dose levels, 46 percent (12 of 26) experienced a MCyR, with 31 percent (8 of 26)
a complete cytogenetic responses (CCyR). In patients treated at dose levels
equal to or greater than 30 mg/day, the MCyR rate in chronic phase patients is
58 percent (7 of 12). Three of twelve evaluable patients with accelerated phase,
blast phase or Ph+ ALL experienced a MCyR (including one CCyR).
* A complete hematologic response (CHR) was observed in 85 percent (22 of 26) of
chronic phase CML patients evaluable for hematologic response (16 patients
entered the study with a baseline CHR). A major hematologic response was
observed in five of twelve (42 percent) evaluable patients with accelerated
phase, blast phase or Ph+ ALL.
* Anti-leukemic activity was seen in patients with resistant BCR-ABL mutations.
Of the 21 CML patients with the T315I mutation in the study, 57 percent (12 of
21) have chronic phase disease. Nine of these patients are currently evaluable
for response: eight (89 percent) have achieved a CHR and six (67 percent) have
experienced a MCyR (including CCyR in 5 patients).

“These are remarkable results that now suggest that responses to AP24534 are
persistent and include molecular responses in heavily pretreated patients with
resistant leukemia,” said Frank G. Haluska, M.D., Ph.D., vice president,
clinical affairs at ARIAD. “With a larger number of patients and longer term
follow-up, the response rates continue to be highly encouraging, and the
clinical benefit from AP24534 appears to be durable. The data provide evidence
that AP24534 is well tolerated at therapeutic dose levels and constitute the
foundation for our pivotal trial to begin in the second half of this year.”

AP24534 Poster and Investigator Slides

The poster and investigator slides on the additional safety and clinical data of
AP24534 being presented at ASCO can be accessed by visiting the investor
relations section of ARIAD`s website at http://investor.ariad.com

About CML and Ph+ ALL

CML is characterized by an excessive and unregulated production of white blood
cells by the bone marrow due to a genetic abnormality that produces the BCR-ABL
protein. After a chronic phase of production of too many white blood cells, CML
typically evolves to more aggressive phases such as accelerated or blast crisis.
Ph+ ALL is a subtype of acute lymphoblastic leukemia that carries the Ph+
chromosome that produces BCR-ABL. It has a more aggressive course than CML and
is often treated with a combination of chemotherapy and tyrosine kinase
inhibitors. Because both of these diseases express the BCR-ABL protein, this
would render them potentially susceptible to treatment with AP24534.

About ARIAD

ARIAD`s vision is to transform the lives of cancer patients with breakthrough
medicines. The Company`s mission is to discover, develop and commercialize
small-molecule drugs to treat cancer in patients with the greatest and most
urgent unmet medical need – aggressive cancers where current therapies are
inadequate. ARIAD`s lead product candidate, ridaforolimus, is an investigational
mTOR inhibitor being developed by Merck Sharpe & Dohme Corp. and is in Phase 3
clinical development in patients with advanced sarcomas. ARIAD`s second
internally discovered product candidate, AP24534, is an investigational
pan-BCR-ABL inhibitor completing Phase 1 clinical development in patients with
hematological cancers, notably chronic myeloid leukemia. For additional
information about the Company, please visit http://www.ariad.com.

This press release contains “forward-looking statements” including, but not
limited to, statements relating to the updated clinical data for AP24534,
continued enrollment in the Phase 1 clinical trial, the potential for data from
this trial forming the basis for a pivotal registration trial of AP24534 and the
timing of the start of such trial. Forward-looking statements are based on
management’s expectations and are subject to certain factors, risks and
uncertainties that may cause actual results, outcome of events, timing and
performance to differ materially from those expressed or implied by such
statements. These risks and uncertainties include, but are not limited to,
preclinical data and early-stage clinical data that may not be replicated in
later-stage clinical studies, the costs associated with our research,
development, manufacturing and other activities, the conduct, timing and results
of pre-clinical and clinical studies of our product candidates, the adequacy of
our capital resources and the availability of additional funding, and other
factors detailed in the Company’s public filings with the U.S. Securities and
Exchange Commission. The information contained in this press release is believed
to be current as of the date of original issue. The Company does not intend to
update any of the forward-looking statements after the date of this document to
conform these statements to actual results or to changes in the Company’s
expectations, except as required by law.

Gleevec® and Tasigna® are registered trademarks of Novartis AG, and Sprycel® is
a registered trademark of Bristol-Myers Squibb, Inc.

ARIAD Pharmaceuticals, Inc.
Maria E. Cantor, 617-621-2208

Copyright Business Wire 2010

Hyatt Continues Global Expansion of Andaz Brand Hotels in Prime Urban and Resort Locations

11 Andaz Properties Now Open or Under Development Worldwide
CHICAGO–(Business Wire)–
Hyatt Hotels Corporation (NYSE: H) announced today the signing of management
agreements for three new Andaz properties. The hotels will be located in Sanya
Sunny Bay, China; Delhi, India; and Providenciales, Turks and Caicos. These
planned properties, situated in prime urban and resort locations, will be the
latest additions to the expanding Andaz brand, which only three years after its
debut, includes 11 properties open or under development in six countries.

Personal and uncomplicated, Andaz is a new hotel experience that blends fresh,
engaging hospitality with stylish, vibrant settings, created with simplicity and
locality in mind. These new properties will join Andaz Liverpool Street, London
(2007), Andaz West Hollywood (2009), Andaz Wall Street (2010) and Andaz San
Diego (2010). Andaz 5th Avenue is scheduled to open in New York in summer 2010.
Previously announced planned openings include Andaz Austin, Texas; Andaz
Amsterdam; and Andaz Papagayo, Costa Rica.

“The Andaz brand is quickly taking hold in the lifestyle hospitality category
and is a key component of Hyatt`s strategy of increasing our presence in key
markets around the world where we see growth potential,” said Steve Haggerty,
global head of real estate and development, Hyatt Hotels Corporation. “The
momentum behind Andaz is a testament to the brand`s global appeal, and Hyatt`s
well-established reputation as a preferred management company.”

The 183-room Andaz Sanya Sunny Bay, which will be located in a large scale
mixed-use resort community on the southern oceanside of China`s Hainan Island,
will be complemented by the 196-room Park Hyatt Sanya Sunny Bay and branded
villas. With a mountain on one side and a white sand beach facing the South Sea
on the other, Andaz Sanya Sunny Bay will offer five restaurants, as well as a
2,500-square-foot ballroom and three meeting rooms. The hotel will share a
variety of amenities with Park Hyatt Sanya Sunny Bay, including a Spa Village
featuring an outdoor swimming pool, beach club, fitness center, extensive spa
facilities and treatment rooms, as well as a restaurant, tea house, and bakery.
The hotel will be developed by Sunny Bay Development Company.

Slated to open in 2013, Andaz Delhi, a 323-room hotel with an additional 118
Andaz-branded apartments, will be located in India`s second-largest metropolis
which is also a leading economic center. The hotel, which will be developed by
Juniper Hotels Private Limited, will be part of the burgeoning Hospitality
District, near Indira Gandhi International Airport and close to Delhi`s emerging
Central Business District and the commercial hubs of Gurgoan and South Delhi.
The hotel will feature a variety of amenities including a lounge, theme bar, two
restaurants, spa, and fitness center. Additionally, the property will offer a
7,000-square-foot ballroom and seven meeting rooms. The project, the first Andaz
property planned in India, comes two months after Hyatt announced plans to
expand its presence in Delhi, Goa, Kolkata and Mumbai, as well as expand into 15
new Indian markets over the next five years.

The 170-key Andaz Turks and Caicos, scheduled to open in 2014 on the central
island of Providenciales in Turks and Caicos, will include approximately 76
Andaz-branded condominium residences and three villas which owners can choose to
place into an Andaz-managed rental program. Situated on a 21-acre property along
a 2,700-foot crescent-shaped oceanfront parcel, the hotel will feature a variety
of amenities including several restaurants, an outdoor pool, spa and fitness
center. Additionally, the property will offer several options for events and
meetings, including five Andaz Studios, two trellised courtyards, an event
gallery, and a studio display kitchen. The hotel, which will be developed by the
Cloisters Group, will be located approximately 15 minutes by car from
Providenciales International Airport.

About Andaz

Global in scale while local in perspective, Andaz delivers an innovative
hospitality experience and attentive, uncomplicated service designed to
accommodate guests` personal preferences. Hotels in this unique collection
reflect the spirit of their locale, and are dedicated to creating natural and
vibrant living spaces where travelers can indulge in their own personal sense of
comfort and style. For more information and reservations, visit www.andaz.com.

About Park Hyatt

Intimate and residential in style, Park Hyatt hotels promise elegant and
gracious service on a personal scale, and are further distinguished by prime
locations and exceptional interior design. Hyatt Hotels & Resorts and its
subsidiaries operate 24 Park Hyatt brand hotels. Current locations include:
Baku, Beaver Creek, Beijing, Buenos Aires, Canberra, Chicago, Dubai, Goa,
Hamburg, Istanbul, Jeddah, Melbourne, Mendoza, Milan, Moscow, Paris, Saigon,
Seoul, Shanghai, Sydney, Tokyo, Toronto, Washington, DC and Zurich.

About Hyatt Hotels Corporation

Hyatt Hotels Corporation, headquartered in Chicago, is a leading global
hospitality company with a proud heritage of making guests feel more than
welcome. Thousands of members of the Hyatt family in 45 countries strive to make
a difference in the lives of the guests they encounter every day by providing
authentic hospitality. The company`s subsidiaries manage, franchise, own and
develop hotels and resorts under the Hyatt, Park Hyatt, Andaz, Grand Hyatt,
Hyatt Regency, Hyatt Place and Hyatt Summerfield Suites brand names and have
locations under development on five continents. Hyatt Vacation Ownership, Inc.,
a Hyatt Hotels Corporation subsidiary, develops and operates vacation ownership
properties under the Hyatt Vacation Club brand. As of March 31, 2010, the
company`s worldwide portfolio consisted of 434 properties. For more information,
please visit www.hyatt.com.

About Sunny Bay Development Company

Sunny Bay Development Company is a development subsidiary of DTW Group, a
leading Chinese logistic company. The DTW Group was founded in 1992,
headquartered in Beijing and currently operates 33 integrated logistics
distribution centers, 23 international freight forwarding stations, 7 bonded
warehouses, 114 network hubs. Through this network DTW Group is present in all
major cities and economic regions in China where it provides outstanding
services for domestic transportation, international freight forwarding,
warehousing and contract logistics services. DTW Group was the former JV partner
of Fedex in China.

About Juniper Hotels Private Limited

Juniper Hotels Private Limited (JHPL) is a hotel investment company co-owned by
Two Seas Holdings Limited, and Saraf Holdings Limited. JHPL owns Grand Hyatt
Mumbai and Hyatt Regency Ahmedabad in Western India, scheduled to open in 2013.
Saraf Holdings, a developer of Hyatt hotels in India through its affiliates also
own hotels under the Hyatt Regency brand in Kolkata (Eastern India), which
opened in 2002; Chennai in Southern India, scheduled to open in 2010; and
Kathmandu, a luxury five-star resort in Kathmandu, Nepal, which opened in 2000.

About Cloisters Group

The Cloisters group of companies, which is led by Antonio Dallamano, was
established specifically to develop Andaz Turks and Caicos. The partners, who
are all long term residents of the Turks and Caicos Islands, have extensive
international business experience in development projects.

Forward Looking Statements

Statements in this press release, which are not historical facts, are
“forward-looking” statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements include statements about our
plans, strategies, financial performance, prospects or future events and involve
known and unknown risks that are difficult to predict. As a result, our actual
results, performance or achievements may differ materially from those expressed
or implied by these forward-looking statements.In some cases, you can identify
forward-looking statements by the use of words such as “may,” “could,” “expect,”
“intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,”
“potential,” “continue,” “likely,” “will,” “would” and variations of these terms
and similar expressions, or the negative of these terms or similar expressions.
Such forward-looking statements are necessarily based upon estimates and
assumptions that, while considered reasonable by us and our management, are
inherently uncertain.Factors that may cause actual results to differ materially
from current expectations include, among others, the depth and duration of the
current economic downturn; levels of spending in the business, travel and
leisure industries as well as consumer confidence; declines in occupancy and
average daily rate; hostilities, including future terrorist attacks, or fear of
hostilities that affect travel; travel-related accidents; changes in the tastes
and preferences of our customers; relationships with associates and labor unions
and changes in labor law; the financial condition of, and our relationships
with, third-party property owners, franchisees and hospitality venture partners;
risk associated with potential acquisitions and dispositions and the
introduction of new brand concepts; changes in the competitive environment in
our industry and the markets where we operate; outcomes of legal proceedings;
changes in federal, state, local or foreign tax law; fluctuations in currency
exchange rates; general volatility of the capital markets and our ability to
access the capital markets. A more complete description of these risks and
uncertainties can be found in our filings with the Securities and Exchange
Commission. We caution you not to place undue reliance on any forward-looking
statements, which are made as of the date of this press release. We undertake no
obligation to update publicly any of these forward-looking statements to reflect
actual results, new information or future events, changes in assumptions or
changes in other factors affecting forward-looking statements, except to the
extent required by applicable laws. If we update one or more forward-looking
statements, no inference should be drawn that we will make additional updates
with respect to those or other forward-looking statements.

Farley Kern
Hyatt Hotels & Resorts
+1 312 780 5506
farley.kern@hyatt.com

Copyright Business Wire 2010

Grant Thornton LLP Business Optimism Index Returns to Pre-Crisis Level

44% Of Business Leaders Plan to Increase Hiring in Next Six Months
CHICAGO–(Business Wire)–
Grant Thornton LLP`s Business Optimism Index, a quarterly survey of U.S.
business leaders, increased significantly to 67.6 in May from 58.8 in February.
Business leaders are becoming much more optimistic, with 63 percent expecting
the U.S. economy to improve in the next six months, up from 43 percent in
February. The hiring outlook is the best it has been since 2007 – 44 percent of
business leaders report that their companies will increase hiring in the next
six months, with only 12 percent saying that their companies will decrease the
number of people they employ.

Business leaders` view of their own businesses also improved, with 87 percent
feeling optimistic about their companies` growth over the next six months,
compared with 74 percent in February.

With regard to the recession, a quarter (24%) think that it will end in 2010,
while nearly half (48%) say it will take until some time in 2011 for the economy
to come out of recession. One out of six executives (16%) says that the
recession is already over.

2/2009 5/2009 8/2009 11/2009 2/2010 5/2010
OVERALL Business Optimism Index 37.6 54.5 60.9 60.4 58.8 67.6
Believe U.S. economy will improve 17% 45% 58% 53% 43% 63%
Believe U.S. economy will worsen 49% 13% 7% 13% 12% 6%
Very or somewhat optimistic about own business 43% 62% 73% 79% 74% 87%
Very or somewhat pessimistic about own business 57% 38% 27% 21% 27% 13%
Plan to increase staff 9% 20% 26% 30% 31% 44%
Plan to decrease staff 45% 30% 18% 18% 18% 12%

When do you think the economy will come out of recession?

11/2009 2/2010 5/2010
Before the end of 2009 10% n/a n/a
First half of 2010 23% 12% n/a
Second half of 2010 46% 27% 24%
2011 19% 37% 48%
Later 3% 12% 12%
The recession is over n/a 12% 16%

* Percentages may not total 100 due to rounding.

About the Grant Thornton Business Optimism Index

The Grant Thornton Business Optimism Index, a quarterly survey of U.S. business
leaders, comprises three measures:

* U.S. economy: Business leaders` perceptions of whether the U.S. economy will
improve, remain the same or deteriorate in the next six months.
* Business growth: Business leaders` perceptions about the growth of their own
businesses over the next six months.
* Hiring expectations: Whether business leaders expect the number of people
their companies employ to increase, remain the same or decrease in the next six
months.

The survey was conducted between May 4 and May 14, 2010, with more than 370
senior executives from various industries responding to the survey. To see all
the survey findings, please visit www.GrantThornton.com/BOI.

About Grant Thornton LLP

Grant Thornton LLP is the U.S. member firm of Grant Thornton International Ltd.

Grant Thornton LLP
Kristi Grgeta
T 312.602.8720
E Kristi.Grgeta@gt.com

Copyright Business Wire 2010

SteelSeries Introduces New R.U.S.E. Edition Xai Laser Mouse and QcK Gaming Surface for RTS Fans

Players Will Excel in Ubisoft`s Game of Strategy and Deception with new
SteelSeries Gaming Peripherals
CHICAGO–(Business Wire)–
SteelSeries has teamed with game publisher Ubisoft to bring fans exclusive
branded peripherals for the upcoming real-time strategy game R.U.S.E. Designed
to give players a competitive advantage, the SteelSeries Xai Laser Mouse
R.U.S.E. Edition enhances performance with its superior technology and a
preconfigured profile setting that optimizes game-play. The preloaded R.U.S.E.
profile, created with input from Ubisoft, allows quick access to the R.U.S.E.
and HQ Menus, and preset macro buttons can take the player from the bird`s eye
view of the war to the heart of the battlefield in an instant. The SteelSeries
QcK Limited Edition (R.U.S.E.) mousepad features graphics from the game and
provides a smooth and consistent glide; combined they deliver a complete and
immersive R.U.S.E. experience.

Currently in open beta, R.U.S.E. allows players to use strategy and bluffing
tactics as the general of their nation`s army during World War II. The speed and
range of movement required in the game, demands tools that can deliver superb
levels of precision and accuracy. Ubisoft chose to partner with SteelSeries,
because of the award-winning, innovative features and technology that the
SteelSeries Xai offers to gamers.

In addition to the R.U.S.E. profile that comes pre-loaded on the SteelSeries Xai
Laser Mouse R.U.S.E. Edition, SteelSeries will offer pro-gamer recommended
R.U.S.E. profiles for users to download once the game launches in June. These
recommended profiles will be found on the SteelSeries web site.

Important features on the SteelSeries Xai Laser Mouse R.U.S.E. Edition include:

* Ambidextrous shape with a 10.8 megapixels/second sensor processing 12,000
frames/second at 5,001 Counts Per Inch (CPI) with movement speeds of 150
inches/second
* Unique SteelSeries sensor innovations including SteelSeries ExactAim,
SteelSeries ExactRate, SteelSeries ExactSens, SteelSeries FreeMove and automatic
lift distance calibration deliver exceptional levels of personalization
* Up to 5 stored profiles including a preconfigured R.U.S.E. profile created
with input from game publisher, Ubisoft
* 7 Programmable macro buttons with up to 200 strokes per button
* Full customization via LCD menu system on the back of the mouse stored by the
hardware – eliminating the need for drivers and providing configuration
capabilities on-the-go.

“R.U.S.E. is a strategy game that we believe players will experience differently
than any other RTS game on the market. In a game where every detail matters,
choosing a mouse that obeys both the eye and every sleight of hand is a good
strategy. With excellent levels of precision and ergonomy, the SteelSeries Xai
mouse could become your best ally,” said Mathieu Girard, Senior Producer at
Ubisoft. “Not only is it fully branded R.U.S.E. on the outside but is programmed
with a special player profile.”

“Industry awards, player feedback and tournament wins have shown us that the
time we spent methodically perfecting the SteelSeries Xai Laser Mouse has paid
off,” said Bruce Hawver, CEO of SteelSeries. “R.U.S.E. players will be easily
impressed with the game`s unique game-play built around an incredible zooming
engine, and with the technology we pack inside the SteelSeries Xai as well as
the smooth glide and graphics of the QcK mousepad it all comes together to
provide gamers with an outstanding RTS experience.”

The SteelSeries QcK Limited Edition (R.U.S.E.) gaming surface is made of high
quality cloth material and an optimized textured surface that guarantees
smoothness and glide. The non-slip rubber base prevents sliding, no matter what
surface the mousepad is on. Official artwork from the game depicts an exciting
battle between opposing forces using the element of deception.

The SteelSeries Xai Laser Mouse R.U.S.E. Edition and QcK Limited Edition
(R.U.S.E.) will retail in North America for $89.99 USD and $14.99 USD online at
SteelSeries.com.

R.U.S.E. is scheduled for release on Windows PC, the Xbox 360 video game and
entertainment system from Microsoft, the PlayStation3 computer entertainment
system on June 8, 2010.

To learn more about R.U.S.E., visit www.rusegame.com.

About SteelSeries

SteelSeries is a leading manufacturer of gaming peripherals and accessories,
including headsets, keyboards, mice, software and gaming surfaces, selling in
more than 75 countries. SteelSeries has been on the forefront of professional
gaming gear since its inception in 2001, thanks to continued innovation and
product development in collaboration with leading professional gamers to ensure
optimum performance and durability. SteelSeries supports the growth of
competitive gaming and electronic sports through professional team sponsorships
and community support all over the world. For more information, please visit
www.SteelSeries.com.

About Ubisoft

Ubisoft is a leading producer, publisher and distributor of interactive
entertainment products worldwide and has grown considerably through a strong and
diversified line-up of products and partnerships. Ubisoft has offices in 28
countries and sales in 55 countries around the globe. It is committed to
delivering high-quality, cutting-edge video game titles to consumers. Ubisoft
generated sales of €1.058 million for the 2008-09 fiscal year. To learn more,
please visit www.ubisoftgroup.com

© 2010, Ubisoft Entertainment. All Rights Reserved. R.U.S.E., Ubisoft, Ubi.com,
and the Ubisoft logo are trademarks of Ubisoft Entertainment in the U.S. and/or
other countries. Developed by Eugen Systems.

“PlayStation”, and the “PS” Family logo are registered trademarks and “PS3″ is a
trademark of Sony Computer Entertainment Inc.

Microsoft, Windows, the Windows Vista Start button, Xbox, Xbox 360, Xbox LIVE
and the Xbox logos are trademarks of the Microsoft group of companies and ‘Games
for Windows’ and the Windows Vista Start button logo are used under license from
Microsoft.

Photos/Multimedia Gallery Available:

http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6249283〈=en

For media inquiries:
Tori Pugliese
SteelSeries PR Manager
tori@steelseries.com
(203) 605-4028

Copyright Business Wire 2010

Cancer Prevention Coalition Challenges “Honest Food Labels” Article

Statement from the Cancer Prevention Coalition
CHICAGO–(Business Wire)–
As reported in a March 18, New York Times editorial, “Honest Food Labels,” FDA
Commissioner, Margaret Hamburg, M.D., publicized letters to 17 food companies
accusing them of — “masking undesirable ingredients” — in their products. She
also emphasized the importance of “providing nutrition information that
consumers can rely on.” Unfortunately, she has failed to take any such action
with regard to the two major dietary staples, milk and meat.

About 20% of our milk is genetically engineered, technically known as rBGH
(recombinant Bovine Growth Hormone), which contains high levels of a natural
growth factor known as IGF-1 (Insulin-like Growth Factor one). This survives
digestion and is readily absorbed from the small intestine into the blood.
Increased levels of IGF-1 have been shown to increase risks of breast cancer in
19 scientific publications, risks of colon cancer in 10 publications, and
prostate cancer in 7 publications. Of further concern, increased IGF-1 levels
block natural defense mechanisms against early microscopic cancers, known as
apoptosis.

Based on these concerns, on June 3, 1999, the United Nations Food Safety Agency,
representing 101 nations worldwide, ruled unanimously not to endorse or set
safety standards for rBGH milk. Effectively, this has resulted in an
international ban on U.S. milk.

Also based on these concerns, the Cancer Prevention Coalition, endorsed by five
leading national experts, petitioned the FDA in May 2007 to label rBGH milk with
an explicit cancer warnings. In the absence of any response, we resubmitted this
petition in January 2010 to Dr. Hamburg, and are waiting for a response.

U.S. cattle are implanted with natural or synthetic sex hormones prior to
entering feed lots 100 days prior to slaughter in order to increase their meat
yield. Not surprisingly, our meat is contaminated with high levels of sex
hormones. Based on these concerns, and as warned by the Cancer Prevention
Coalition and five leading national experts, our meat poses increased risks of
hormonal cancers, which have escalated since 1975: breast by 23%, prostate by
60%, and testis by 60%. Not surprisingly, U.S. meat is banned worldwide.

Furthermore, as clearly evidenced in a series of General Accounting Office
investigations and Congressional hearings, the FDA, besides the U.S. Department
of Agriculture (USDA), have failed to take any regulatory action to protect the
public from the dangers of hormonal meat. A 1986 report, “Human Food Safety and
Regulation of Animal Drugs,” unanimously approved by the House Committee on
Government Operations, concluded that the “FDA has consistently disregarded its
responsibility — has repeatedly put what it perceives are interests of
veterinarians and the livestock industry ahead of its legal obligation to
protect consumers — jeopardizing the health and safety of consumers meat, milk,
and poultry.”

In response to questions on the dangers of hormonal meat raised by the European
Commission in February 1996, the USDA responded with unsubstantiated claims that
less than 0.25% of animals tested annually proved positive for “residue
violations.” In fact, meat has not been and is still not monitored for sex
hormone levels by the USDA or FDA.

Together with other leading scientific experts, on January 29, 2010, the Cancer
Prevention Coalition submitted a Citizens Petition to the FDA on the “Imminent
health Hazard” from hormonal meat, supported by 59 scientific references. We are
waiting for a response.

Not surprisingly, U.S. milk and meat are virtually banned worldwide.

Samuel S. Epstein, M.D.
Professor emeritus Environmental & Occupational Medicine
University of Illinois Chicago School of Public Health
Chairman, Cancer Prevention Coalition
email: epstein@uic.edu
www.preventcancer.com
To subscribe: http://ens-news.net/lists/?p=subscribe&id=9

Copyright Business Wire 2010